Delivery Order SPE2DB22D3016-SPE2DB24FBGA9
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 100 capsules of the prescription medication Vyvanse 30 mg. The award date is September 16, 2024, with an ultimate completion date of September 17, 2024. The ceiling value of this delivery order is $3,499.78. The contract is a firm fixed-price type and does not have a set-aside designation. Amerisourcebergen is a...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of 100 units of the pharmaceutical drug Vyvanse (40 mg capsules). The total potential value of this order is $1,012.50, with a completion date of February 23, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical products, including Vyvanse 60 mg capsules. The order has a ceiling value of $3,679.94 and a performance period extending through April 29, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,467.10 firm fixed-price contract is for the supply of 100 capsules of the prescription drug Vyvanse 60 mg. The delivery order has a completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for 4,565,927,942 units of Vyvanse 10 mg capsules, a prescription medication. The firm-fixed-price contract has a ceiling value of $11,732.46 and a completion date of September 25, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,565,700 units of Vyvanse 50mg capsules. The $1,127.17 award is a firm fixed-price contract with an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is a for-profit organization that holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies to provide a wide range of...
- This is a $1,649.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of Vyvanse 40 mg capsules, a prescription medication, with an ultimate completion date of August 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds numerous Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $1,341.31, is for the supply of 4,565,580,632 units of the pharmaceutical product Vyvanse 60 mg capsules. The contract has a performance period that extends through August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,729.58 award is for the provision of 100 units of the 40 milligram strength capsule form of the prescription medication Vyvanse. This delivery order does not utilize any set-aside designations. Amerisourcebergen Drug Corp is also the prime contractor on a...
- This is a $1,219.25 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order is for 100 units of the medication Vyvanse 50 mg capsules, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, which serves as the primary vehicle for...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FBGA9Delivery Order
This is a delivery order under a larger contract vehicle awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The order is for 100 units of the prescription drug Vyvanse 60 mg capsules, with a ceiling value of $2,597.22. The delivery order has a firm-fixed price and an ultimate completion date of September 6, 2024. No set-aside designation was used for this award. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds several Indefinite Delivery Contracts (IDCs) with DLA and other agencies, valued up to $999,999,999 and $750,000, respectively, for providing a comprehensive range of medical commodities to support federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/5/24 |